Resources

The messages within this document can be used by advocates, program implementers, and others who seek to promote increased access to and availability of affordable, quality-assured medicines, technologies and other health supplies for reproductive, maternal, newborn, child and adolescent health.

PATH’s advocacy work builds on and continues global efforts to expand access to simple, essential, and affordable medicines, medical devices, and other health supplies to prevent deaths of women and children worldwide.

In 2014, PATH conducted interviews with stakeholders in Senegal and Uganda to assess receptivity to self-injection of the contraceptive, subcutaneous DMPA (DMPA-SC, brand name Sayana Press) as well as the evidence requirements and processes necessary to chart a course for adoption, introduction, and scale-up of self-injection as a service-delivery practice in the two countries. For more information, email FPoptions@path.org or visit www.path.org/dmpa-sc.

This fact sheet highlights PATH’s work to address rotavirus, the leading cause of severe diarrheal disease. It includes general information about our efforts to increase access to and effectiveness of existing vaccines, as well as to develop new vaccines and to raise awareness through advocacy.

A report that describes the work that defined the first decade of the PATH Malaria Control and Elimination Partnership in Africa (MACEPA).